These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27415446)

  • 1. Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer.
    Journy NM; Morton LM; Kleinerman RA; Bekelman JE; Berrington de Gonzalez A
    JAMA Oncol; 2016 Oct; 2(10):1368-1370. PubMed ID: 27415446
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
    Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
    Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced second cancers: the impact of 3D-CRT and IMRT.
    Hall EJ; Wuu CS
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):83-8. PubMed ID: 12694826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
    Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
    Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
    [No Abstract]   [Full Text] [Related]  

  • 5. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
    Morimoto M; Yoshioka Y; Konishi K; Isohashi F; Takahashi Y; Ogata T; Koizumi M; Teshima T; Bijl HP; van der Schaaf A; Langendijk JA; Ogawa K
    Tumori; 2014; 100(3):265-71. PubMed ID: 25076236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
    Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy.
    Bezak E; Takam R; Yeoh E; Marcu LG
    Phys Med; 2017 Oct; 42():253-258. PubMed ID: 28302493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late toxicity after conformal and intensity-modulated radiation therapy for prostate cancer: impact of previous surgery for benign prostatic hyperplasia.
    Odrazka K; Dolezel M; Vanasek J; Vaculikova M; Zouhar M; Sefrova J; Paluska P; Vosmik M; Kohlova T; Kolarova I; Navratil P; Brodak M; Prosvic P; Hoffmann P
    Int J Urol; 2010 Sep; 17(9):784-90. PubMed ID: 20604816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.
    Ruben JD; Davis S; Evans C; Jones P; Gagliardi F; Haynes M; Hunter A
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1530-6. PubMed ID: 18207670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity modulated radiation therapy replaces 3-dimensional conformal radiotherapy as prostate cancer treatment.
    Elliott SP; Adejoro OO; Konety BR; Jarosek SL; Dusenbery KE; Virnig BA
    J Urol; 2012 Apr; 187(4):1253-8. PubMed ID: 22335868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heterogeneity of leukemia occurring after treatment for sarcoma.
    Varterasian M; Zalupski M; Karanes C
    Am J Clin Oncol; 1997 Dec; 20(6):585-6. PubMed ID: 9391546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second neoplasms after percutaneous radiotherapy].
    Haidl F; Pfister D; Semrau R; Heidenreich A
    Urologe A; 2017 Mar; 56(3):342-350. PubMed ID: 27844130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute non-lymphocytic leukaemia and myelofibrosis following sequential hemibody irradiation for prostatic carcinoma.
    Graham P
    Clin Oncol (R Coll Radiol); 1992 May; 4(3):203. PubMed ID: 1586642
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary leukemia: twice is a coincidence?
    Akerley W
    Cancer; 2000 Feb; 88(3):497-9. PubMed ID: 10649239
    [No Abstract]   [Full Text] [Related]  

  • 18. Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy.
    Yoshimura K; Kamoto T; Nakamura E; Segawa T; Kamba T; Takahashi T; Nishiyama H; Ito N; Takayama K; Mizowaki T; Mitsumori M; Hiraoka M; Ogawa O
    Prostate Cancer Prostatic Dis; 2007; 10(3):288-92. PubMed ID: 17160068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental Dose to Pelvic Nodal Regions in Prostate-Only Radiotherapy.
    Murthy V; Lewis S; Sawant M; Paul SN; Mahantshetty U; Shrivastava SK
    Technol Cancer Res Treat; 2017 Apr; 16(2):211-217. PubMed ID: 27492806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study.
    Advani PG; Schonfeld SJ; Curtis RE; Dores GM; Linet MS; Sigel BS; Lam CJK; Tucker MA; Chanock SJ; Morton LM
    Leukemia; 2019 Dec; 33(12):2947-2978. PubMed ID: 31341236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.